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Abstract 
Background: SYNE1 ataxia is an autosomal recessive hereditary condition, the main characteristic features of which 
are gait and limb ataxia and cerebellar dysarthria. Reports have revealed that the clinical phenotype of SYNE1 ataxia is 
more complex than the first published cases with pure cerebellar signs indicated. The aim of this study was to charac-
terize eye movement alterations in the first diagnosed Hungarian SYNE1 ataxia patients.
Results: Saccades and antisaccades were examined with an eye tracker device in 3 SYNE1 (one patient has two 
frameshift mutations [c.8515_8516insA, p.Met2839Asnfs*53 and c.11594_11595insG, p.Glu3866*] in a compound 
heterozygous state, whereas two subjects have a splicing variant [c.23146-2A > G] in a homozygous state), 6 Friedreich 
ataxia (FA) patients and 12 healthy controls. Besides that, detailed clinical phenotyping and comprehensive neuropsy-
chological assessment were carried out in all patients with ataxia.
In addition to the characteristic cerebellar alterations, pyramidal signs and polyneuropathy were observed at least 
in 2 SYNE1 ataxia patients, for which no other underlying reason was found. The eye tracking assessment revealed 
hypometric saccades in the longer amplitude (18.4°) saccadic paradigm in all SYNE1 patients, whereas 2 out of 3 
SYNE1 subjects performed slow saccades as well. In the antisaccade task, higher incorrect ratios of antisaccades were 
demonstrated in SYNE1 patients compared to healthy controls, showing inverse correlation with working memory 
test results. The corresponding data of FA patients was dispersed over a wide range, partially overlapping with control 
data.
Conclusions: The current study draws attention to the presence of eye movement disorders in patients with SYNE1 
ataxia and demonstrates that alterations in the antisaccade paradigm may be related to working memory deficits.
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Background
Autosomal recessive cerebellar ataxias (ARCA) belong 
to a continuously expanding group of hereditary neuro-
degenerative disorders. Recently, more than 100 genes 
have been identified which can cause ARCA, including 
the SYNE1 gene (OMIM 608,441). SYNE1 is one of the 
largest genes in the human genome, located in 6p25 
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gene encodes a peptide of about 8797 amino acids, 
known as Nesprin 1 (Nuclear envelope spectrin 1) [1]. 
It is a member of the spectrin family of proteins and its 
major function is to link the plasma membrane to the 
actin cytoskeleton [2]. Nesprin 1 has three domains, 
including the N-terminal actin binding domain (also 
called calponin homology domain), multiple spec-
trin repeats and the C-terminal KASH domain (also 
knowns as Klarsicht domain) [1]. In 2007, Gros-Louis 
et al. reported 26 French-Canadian families from Que-
bec, Canada with slowly progressive pure cerebellar 
hereditary ataxia caused by truncating mutations of 
the SYNE1 gene. The name of this disease was auto-
somal recessive cerebellar ataxia type 1 (ARCA1), also 
known as spinocerebellar ataxia, autosomal recessive 
8 (SCAR8), or recessive ataxia of Beauce [1]. In the 
following years, SYNE1 ataxia was observed almost 
exclusively in Quebec, Canada [1, 3]. From 2013, some 
sporadic cases were reported outside the French-Cana-
dian population as well [4–7]. In 2016, Synofzik and 
Mademan et  al. described 33 non-Canadian patients 
with SYNE1 ataxia from a large multi-center study, 
which indicated that mutations of SYNE1 gene are 
much more common causes of ARCA than previously 
thought [2, 8]. Besides its frequency, the clinical phe-
notype was also more complex than the first described, 
purely cerebellar disease. Most of the newly identified 
patients had extracerebellar neurological signs, includ-
ing upper and lower motoneuron symptoms, and non-
neurological abnormalities, including scoliosis, pes 
cavus or respiratory dysfunction with severe manifesta-
tion. Only a small portion of these subjects showed the 
classical pure cerebellar phenotype [2, 8].
Moreover, mutations of SYNE1 gene have been 
associated with arthrogryposis multiplex congenita, 
Emery-Dreifuss muscular dystrophy 4, dilatative and 
hypertrophic cardiomyopathy, intellectual disability, 
blepharospasm, autism spectrum disorder and schizo-
phrenia [9–16].
After reviewing the clinical phenotype of the previ-
ously published 168 SYNE1 ataxia patients, it was noted 
that detailed characterization of eye movements had 
not yet been performed, only the occurrence of gaze-
evoked nystagmus, slowing of saccades, broken up 
smooth pursuits, strabismus and square-wave jerks 
were reported [1–4, 17–19].
In this paper we aimed to characterize the saccadic 
and antisaccadic eye movements of 3 Hungarian SYNE1 
ataxia patients and compare them to the same param-
eters of Friedreich ataxia (FA) patients and healthy sub-




9 patients with unknown cerebellar ataxia and 12 
healthy controls (HC) were enrolled in the study. The 
patients underwent a detailed diagnostic approach 
including neurological examination, laboratory and 
radiological investigations to exclude acquired causes 
of ataxia. Scale for the Assessment and Rating of Ataxia 
(SARA) scores were recorded in all cases. After obtain-
ing written, informed consent, genomic DNA was 
extracted from peripheral blood leukocytes by standard 
protocol. First, according to recent guidelines on the 
management of sporadic ataxias without known sec-
ondary etiology [20], the most common repeat expan-
sion hereditary ataxias (spinocerebellar ataxia (SCA) 1, 
2, 3, 6, 7 and FA) were tested. If these genetic tests did 
not confirm the diagnosis, new generation sequencing 
(NGS) was performed.
For proband AT-04, whole exome sequencing (WES) 
was performed with SureSelectXT Human kit All Exon 
v7 (Agilent, Agilent Technologies, Santa Clara, CA) 
according to the manufacturer’s instructions and paired-
end sequenced (2 × 100  bp) on HiSeq 1500 (Illumina, 
San Diego, CA, USA). Prioritized variants were validated 
in the proband, in the parents of the proband and in his 
brother by amplicon deep sequencing performed using 
Nextera XT Kit (Illumina) and sequenced on HiSeq 1500 
(Illumina).
For subjects AT-05 and AT-06, a total of 60  ng of 
genomic DNA was used for library preparation and 
sequenced with Trusight One clinical exome kit (Illu-
mina) on Illumina MiSeq platform. The clinical exome 
kit covers the coding region of 4813 clinically relevant, 
disease-associated genes. The 150  bp paired reads were 
aligned to the GRCh37.75 human reference genome by 
Burrows Wheel Aligner (BWA v0.7.9a) software. The var-
iants were called by Genome Analysis Toolkit Haplotype-
Caller (GATK v3.5) best practice; annotated by SnpEff 
and VariantStudio softwares. Variants were filtered 
based on severity and frequency against public variant 
databases, including dbSNP, ClinVar, ExAC, EVS and an 




The system and paradigm that were used are described 
in a previous study [21]. The assessment was performed 
in a well-lit room. Subjects sat in front of the monitor 
and their heads were fixed at a distance 60 cm from the 
screen. We used a Tobii TX300 eye tracker and tasks 
were programmed in Psychophysics Toolbox V 3.0.12, 
Page 3 of 12Szpisjak et al. BMC Neurosci            (2021) 22:7  
under MatLab. Before every paradigm, a five-points cali-
bration was performed.
Saccade task
Subjects accomplished the following visually guided sac-
cade task: a black cross appeared at the center of the 
screen and 1.2–2  s later it jumped to the right or left 
side of the screen. The background was grey and the 
distances of displacement of the cross were 9.2° or 18.4° 
horizontally. All measurements were repeated 20 times 
in a pseudorandom order, this means 80 measurements 
per subject. The participants had to shift their gaze to the 
new position of the target as fast and accurately as they 
could. There was a break half-way through the task to 
prevent subjects tearing and/or tiring.
Antisaccade task
In the antisaccade task, the simple antisaccade paradigm 
was used [22]. The composition was similar to the visu-
ally guided saccade paradigm, however, the participants 
had to direct their gaze in the opposite direction (e.g. if 
the target appeared on the left side, they had to look to 
the right side). We explained explicitly the antisaccade 
paradigm to the patients before the task and answered 
their questions. We particularly highlighted for the par-
ticipants that the antisaccade task needs more attention. 
Before the trial, all patients confirmed that they under-
stood the task instructions. Only horizontal movements 
were recorded, as in the saccade task. There was also a 
break after the first half of the trial.
Data acquisition and processing
Data recording began when the target jumped to the 
periphery and stayed there for one second. The record-
ing frequency was 300 Hz and both eyes were registered 
separately. We used a semi-automatic, in-house script to 
define parameters of saccades, as described in a previ-
ous study [21]. The following parameters were measured: 
peak velocity, latency, amplitude, gain and duration. In 
the saccade task, we assessed the main sequence relation-
ships of duration versus amplitude and peak velocity ver-
sus amplitude using the linear model [23]. Additionally, 
in the antisaccade paradigm the incorrect ratio of anti-
saccades was also examined. It is a quotient showing the 
incorrectly executed antisaccades, calculated as incor-
rect/(incorrect + correct) antisaccades.
Neuropsychological assessment
The enrolled ataxia patients were assessed via cogni-
tive examination performed by trained neuropsycholo-
gists. The global cognitive performance was measured by 
Addenbrooke’s Cognitive Examination (ACE) including 
the Mini-Mental State Examination (MMSE). Executive 
function was evaluated by verbal and semantic fluency 
tests. In addition, working memory and the ability to 
maintain and manipulate information were estimated by 
the Backward Digit Span Task (BDST) and the Listening 
Span Task (LST). The quality of information planning and 
visuo-constructional and visual organizational abilities 
were assessed by the Rey Complex Figure Test (RCFT).
Results
Patients
The repeat expansion examinations verified the FA diag-
nosis of 6 patients. All of them had homozygous GAA 
repeat expansions in the first intron of the FXN gene. The 
remaining three patients had negative repeat expansion 
tests, therefore NGS was performed and it confirmed 
SYNE1 gene abnormalities. The mean age of FA patients 
and HC group participants was the same, and the three 
SYNE1 patients were in a similar age range. The demo-
graphic and clinical data of FA and SYNE1 patients and 
healthy subjects are summarized in Table  1, while the 
thorough clinical and genetic characteristics of SYNE1 
patients are detailed here. AT-04 subject was the second 
child of Hungarian, non-consanguineous parents. There 
was no neurological disease in his family. His first symp-
tom was gait ataxia at the age of 15  years. He also had 
delayed puberty in this period. Later, slurred speech also 
appeared and his gait imbalance progressed. The neuro-
logical examination revealed gaze-evoked horizontal nys-
tagmus, cerebellar dysarthria, bilateral Babinski sign, gait 
ataxia and severe lower limb ataxia and mild numbness 
in the upper extremities. Sometimes stimulus sensitive 
myoclonic jerks could also be observed. He had strabis-
mus and myopia with negative fundoscopy. Electroneu-
rography showed mild axonal sensory polyneuropathy. 
Currently, the patient requires walking sticks because of 
the progression of his symptoms. Laboratory examina-
tion did not find pathological abnormalities. Brain MRI 
was performed after sixteen years of disease course and 
displayed moderate cerebellar atrophy with preserved 
brainstem and supratentorial structures (Fig. 1a, b).
WES of AT-04 patient revealed a com-
pound heterozygote state in SYNE1 gene 
NM_033071.3:c.8515_8516insA, p.Met2839Asnfs*53 and 
NM_033071.3:c.11594_11595insG, p.Glu3866* (Fig.  2a). 
The c.8515_8516insA variant located in exon 55 out 
of 146 was inherited from the mother of the proband, 
while c.11594_11595insG located in exon 71 was inher-
ited from the father, and both variants were absent in the 
healthy brother of the proband. None of the frameshift 
variants were found in the gnomAD database (www.
gnoma d.broad insti tute.org) and they are predicted to 
cause the loss of the full-length SYNE1 protein (8750 
amino acids).












































































































































































































































































































































































































































































































































































































































































































































































































































































































Page 5 of 12Szpisjak et al. BMC Neurosci            (2021) 22:7  
The age at onset of AT-05 patient was 30 years and her 
first complaint was gait ataxia, whereas the first symptom 
of her sister (patient AT-06) appeared at 14 years of age 
and was gait abnormality as well. The neurological exam-
ination of both patients revealed cerebellar dysarthria 
and brisk tendon reflexes with bilateral Babinski signs. 
Fig. 1 Brain MRI scans of SYNE1 ataxia patients demonstrated moderate cerebellar atrophy in all subjects and mild cortical atrophy in AT-05 and 
AT-06 patients. a, b: AT-04 patient; c, d: AT-05 patient; e, f: AT-06 patient; a, c, e: sagittal T1 weighted scans; b, d, f: coronal T1-weighted scans
Fig. 2 Genetic abnormalities and consequent alterations of protein of SYNE1 ataxia patients and their parents. a: SYNE1 gene mutations in AT-04 
patient and the parental origin of these variations. b: SYNE1 gene abnormalities in AT-05 and AT-06 subjects and the parental segregation of these 
mutations. The upper parts of the bars denote the DNA sequence, while the lower parts show the encoded amino acids of the protein. Yellow 
bars indicate the pathogenic alleles, white bands mark the normal alleles. Red highlights the nucleotide change of the SYNE1 gene. In part (b), the 
c.23146-2A > G mutation is located in the intron–exon boundary resulting in an abnormal splicing variant
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Truncal ataxia was moderate in the younger patient (AT-
06) and was severe in the elder subject (AT-05). After 
eleven years of disease course patient AT-05 could only 
walk with aids. Mild upper limb and moderate lower 
extremity incoordination developed in the younger sis-
ter, whereas her sibling had moderate superior and severe 
inferior limb ataxia. AT-05 patient has obesity, diabetes 
mellitus, hypertension and hypercholesterolemia, but 
ophthalmological and cardiological investigations were 
normal. AT-06 patient also has the same metabolic dis-
orders, moreover, she has an excavated foot and elec-
troneurography delineated multifocal sensorimotor 
mixed type polyneuropathy. The brain MRI showed mod-
erate cerebellar and very mild cerebral cortical atrophy in 
both patients (Fig. 1c–f). Their non-consanguineous par-
ents did not suffer from ataxia and the younger patient 
has two healthy children.
In AT-05 and AT-06 patients the same homozygous 
NM_182961.3:c.23146-2A > G alteration of the SYNE1 
gene was detected. This intronic variant was not found 
in gnomAD. It causes a TAG–TGG codon change at the 
Intron 128 – Exon 128 boundary resulting in an abnor-
mal splicing variant (Fig.  2b). The presence of these 
mutations was confirmed by targeted Sanger sequenc-
ing. Segregation analysis identified this variant in the het-
erozygous state in both parents of the patients.
Eye tracking
Saccades
The pooled data of leftward and rightward saccades were 
analyzed (Table 2). There was not any relevant difference 
between the three groups of examined subjects in sac-
cadic latencies and durations for either the shorter (9.2°) 
or the longer (18.4°) saccade paradigms. The peak veloci-
ties of saccades of AT-05 and AT-06 patients were smaller 
than the HC subjects and FA patients. However, the peak 
velocities of the saccades of AT-04 patient were similar 
to the subjects of HC and FA groups. In the 9.2° saccade 
task, AT-04 patient demonstrated hypermetric saccadic 
eye movements, whereas the other two SYNE1 ataxia 
patients showed hypometric saccades. Nevertheless, in 
the 18.4° saccade task SYNE1 ataxia subjects performed 
smaller saccadic amplitudes and gain than the healthy 
controls with minimal overlap (Fig.  3a). The amplitudes 
and gain of saccades of FA patients were in a similar 
range to that of the HC group. Figure 4 displays the main 
sequence relationships using the linear model. The dura-
tion vs. amplitude diagram (Fig. 4a) shows that saccades 
of SYNE1 ataxia patients are hypometric and their dura-
tion is longer than in FA or HC groups. The peak velocity 
vs. amplitude graph (Fig. 4b) reinforces that the saccades 
of SYNE1 patients are hypometric and their peak velocity 
is smaller than in HC or FA groups.
Antisaccades
The pooled data of leftward and rightward antisaccades 
were evaluated as well (Table 3). There was no remark-
able difference between the groups with regard to peak 
velocities, latencies and durations of antisaccades. 
The incorrect ratios were higher in the SYNE1 and FA 
patients than in the HC group. However, there was a 
mildly overlapping range in the 9.2° antisaccades within 
the SYNE1 and HC subjects, whereas this was only 
minimally detected in the longer antisaccades (Fig. 3b).
Neuropsychological assessment
The neuropsychological assessment of FA and SYNE1 
patients are summarized in Table 4. The cognitive per-
formance of ataxia patients was compared with the data 
of age- and education-matched standards in the litera-
ture [24–26]. Global cognition was only mildly reduced 
in two FA patients (AT-11 and AT-20), whereas the 
other subjects demonstrated normal ACE and MMSE 
scores. The LST results showed mild abnormalities 
in all SYNE1 patients and in one FA patient, whereas 
the BDST results were decreased more prominently 
in both patient groups. These alterations indicate the 
impairment of working memory and in the ability to 
maintain and manipulate information. Surprisingly, 
the fluency test scores were in the normal range, only 
AT-04 patient demonstrated a mild deficit in the verbal 
fluency test. In addition, the RCFT results were equal 
to the standard outcomes, only AT-05 patient showed a 
mild impairment.
Discussion
In this paper we describe the clinical phenotype and 
characteristics of saccades and antisaccades of the first 
genetically confirmed Hungarian SYNE1 patients caused 
by novel mutations. The cerebellar symptoms of these 
patients involved moderate to severe gait and lower limb 
ataxia and mild to moderate upper limb ataxia and dys-
arthria. Extracerebellar involvement was present as well, 
as all subjects have pyramidal signs and two of the three 
patients have some types of polyneuropathy. Moreover, 
AT-04 patient had strabismus, tactile sensitive myoclonic 
jerks and delayed puberty. In summary, the clinical phe-
notype of subjects is not purely cerebellar, in contrast to 
that described in the first French-Canadian population 
by Gros-Louis et  al. [1], and similar to that of the later 
reported cases [2, 8]. This symptomatic variability sug-
gests that SYNE1 gene plays a broader role in the nor-
mal functioning of the nervous and musculoskeletal 
systems. Consequently, the mutations of this gene can 
cause symptoms and signs over a large spectrum, but 
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an obvious genotype–phenotype correlation cannot be 
established [2].
The eye tracking examination revealed hypometric sac-
cades in the 18.4° paradigm in all SYNE1 patients and in 
two out of three in the 9.2° task. Saccadic dysmetria is a 
cerebellar symptom and it is a common eye movement 
abnormality in hereditary ataxias [27]. This is not a spe-
cific symptom for any type of inheritable ataxia, but there 
may be a higher proportion of hypo- or hypermetric 
saccades, serving as a supporting feature of the disease. 
The hypometria of SYNE1 patients at large amplitude 
stimulus is more pronounced than the well-known mild 
hypometria in healthy subjects observed at higher target 
eccentricities [22]. The hypometria of SYNE1 patients 
is presumably due to the involvement of the cerebel-
lar oculomotor vermis and caudal fastigial nucleus [28]. 
In addition to accuracy, velocity is another impor-
tant characteristic of saccades. Previous case reports 
described slowing of saccades in a portion of SYNE1 
Fig. 3 The most characteristic alterations in saccadic and 
non-saccadic paradigms in SYNE1 ataxia patients. a: saccadic 
amplitude of the 18.4 saccade paradigm in the different groups; 
b: incorrect ratios of the 18.4 antisaccade task in the investigated 
subjects; the circles, triangles and squares denote the parameters 
of healthy controls (HC), Friedreich ataxia patients (FA) and SYNE1 
patients, respectively, and the median values are demonstrated as 
well
Fig. 4 The main sequence relationships of saccades using the linear model. a: saccadic duration versus amplitude; b saccadic peak velocity 
versus amplitude; the red, green and blue dots denote the parameters of healthy controls (HC), Friedreich ataxia patients (FA) and SYNE1 subjects, 
respectively
Table 3 Antisaccade examination in SYNE1 (AT-04–06) and Friedreich ataxia patients and in healthy controls
FA Friedreich ataxia, HC healthy control
Subjects 9.2° antisaccades 18.4° antisaccades
Peak velocity 
(°/s)




Latency (s) Duration (s) Incorrect ratio
AT-04 261.71 0.28 0.053 0.40 290.23 0.29 0.052 0.27
AT-05 232.76 0.32 0.072 0.64 280.16 0.37 0.097 0.36
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patients, however these observations were based exclu-
sively on physical examinations [1–4, 18, 19]. Our find-
ings, obtained by fine eye tracking assessment, confirmed 
the clinical observations of some earlier publications, 
i.e., a high frequency of slow saccades can be detected in 
SYNE1 ataxia. This lower saccadic velocity is likely due to 
brainstem involvement, in particular, the functional loss 
of pontine saccadic burst generator neurons and omni-
pause neurons can explain this observation [23]. Slowing 
of saccades is a characteristic eye movement abnormal-
ity in SCA2 disease. Federighi et  al. examined the sac-
cadic parameters of seven SCA2 patients at similar target 
eccentricities (10 and 18°) to those we used in this study 
and they found more severely reduced peak velocities 
and delayed saccadic latencies compared to controls than 
we detected in two of three SYNE1 patients [23]. Presum-
ably brainstem impairment is more pronounced in SCA2 
than in SYNE1. In addition, saccadic hypometria was not 
found in SCA2 patients, whereas we observed lower sac-
cadic amplitude in SYNE1 patients compared to healthy 
subjects at the larger stimulus paradigm.
The antisaccade assessment showed higher rates of 
incorrectly accomplished antisaccades in both FA and 
SYNE1 patients compared to healthy subjects, whereas 
the other parameters were in similar ranges. The error 
rates were higher on the short stimulus amplitude task 
than on the long amplitude trial. Basically, target eccen-
tricities affect gain, latency and peak velocity, whereas 
its influence on the incorrect ratios is not clear at these 
amplitudes [29–31]. The higher error rate raises the sus-
picion of cognitive impairment, because a strong cor-
relation was demonstrated between antisaccades and 
working memory [32]. The neuropsychological assess-
ment revealed that global cognitive performance was 
normal in SYNE1 patients, whereas executive functions 
were impaired, especially working memory. The perfor-
mance of the examined SYNE1 subjects in BDST and 
LST paradigms inversely correlated with errors in the 
antisaccade tasks, i.e., the most severely affected patient 
in working memory tests (AT-06) had the highest error 
rate in the antisaccade paradigm (Fig. 5). A similar rela-
tionship was not detected in the FA group. Previously 
published studies indicated higher antisaccadic error 
rates in other hereditary and idiopathic cerebellar disor-
ders, including ataxia with oculomotor apraxia type 1, 2, 
ataxia telangiectasia, SCA1, 2, 3 and late onset cerebellar 
ataxia (LOCA) [28, 33–35]. Additionally, Pretegiani et al. 
revealed that SCA2 and LOCA patients showed equally 
poor antisaccade performance irrespective of cortical 
involvement [33]. Additionally, a thorough investigation 
of a SCA2 patient cohort confirmed that impaired anti-
saccade efficacy was associated with executive test defi-
cits, including Stroop interference task and verbal fluency 
test [34]. Our findings draw attention to the major role 
of working memory and inhibitory control in the perfor-
mance of antisaccades, and confirm that executive dys-
function is a prevalent neuropsychological abnormality 
in hereditary ataxias as a part of the cerebellar cognitive 
and affective syndrome [36].
Conclusions
In conclusion, this paper demonstrates the detailed neu-
rological assessment of the first Hungarian SYNE1 ataxia 
patients with novel pathogenic mutations. The eye track-
ing investigation detected some interesting alterations 
regarding both saccades and antisaccades in these sub-
jects, including saccadic hypometria and increased error 
rates for antisaccades. The main weakness of this study 
is the low case number. Nevertheless, these pilot findings 
point out the importance of device-aided examination of 
eye movements in ARCAs. Hopefully in the near future, 
these parameters can be investigated in a larger number 
of SYNE1 patients in order to be able to draw statistical 
conclusions as well.
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